CONNECT TarGeT – a clinical trial into childhood brain cancer

We’re pleased to announce that we’re contributing £1.5m to an ambitious clinical trial that which to accelerate new treatments for childhood brain cancers.

CONNECT TarGeT is an adaptive umbrella clinical trial for people aged…